Clinical Research Directory
Browse clinical research sites, groups, and studies.
Anhydroglucitol in Children With Type 1 Diabetes
Sponsor: University Hospital, Geneva
Summary
The investigators will measure blood levels of 1,5-anhydroglucitol in children with type 1 diabetes and correlate them with parameters related to functional beta-cell mass in diabetic patients. The values will be compared to those obtained in healthy volunteers. Children with newly diagnosed diabetes as well as children with longstanding disease will be included. The aim of the study is to test the validity of 1,5-anhydroglucitol as a novel biomarker of beta-cell mass and function in type 1 diabetes.
Official title: Anhydroglucitol as a Measure of the Functional Beta-cell Mass in Children With Type 1 Diabetes - Pilot Study
Key Details
Gender
All
Age Range
2 Years - 18 Years
Study Type
OBSERVATIONAL
Enrollment
60
Start Date
2023-01-27
Completion Date
2026-12-31
Last Updated
2025-04-02
Healthy Volunteers
Yes
Conditions
Interventions
Measurement of blood levels of 1,5-anhydroglucitol
Measurement of blood levels of 1,5-anhydroglucitol
Locations (1)
University Hospital of Geneva
Geneva, Canton of Geneva, Switzerland